Synonyms that are in the dictionary are marked in green. Synonyms that are not in the dictionary are marked in red.
Antonyms that are in the dictionary are marked in green. Antonyms that are not in the dictionary are marked in red.
Allspring Global Investments Holdings LLC boosted its stake in shares of Azenta, Inc. () by 76.8% during the 3rd quarter, according to its most recent 13F filing with the SEC.
Any biotech investor can look to Azenta as a must-have DNA stock for today.
Source: https://investorplace.com/2023/08/biotech-bonanza-3-top-dna-stocks-with-revolutionary-potential/
Finally, Needham & Company LLC lowered their price objective on shares of Azenta from $78.00 to $68.00 in a research note on Thursday.
Finally, Quadrant Capital Group LLC acquired a new stake in shares of Azenta in the second quarter valued at about $26,000.
FMR LLC acquired a new stake in Azenta during the 2nd quarter worth approximately $172,000.
Source: https://www.americanbankingnews.com/2023/02/10/azenta-nasdaqazta-issues-earnings-results.html
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. boosted its holdings in shares of Azenta by 11.1% in the 1st quarter.
Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its position in shares of Azenta by 11.1% during the 1st quarter.
Quadrant Capital Group LLC lifted its position in Azenta by 82.8% during the fourth quarter.
Quadrant Capital Group LLC purchased a new position in Azenta in the 2nd quarter worth approximately $26,000.
Raymond James initiated coverage on shares of Azenta in a research report on Tuesday, July 18th.
Stephens downgraded Azenta from an “overweight” rating to an “equal weight” rating and reduced their target price for the company from $65.00 to $60.00 in a report on Thursday, February 9th.
Source: https://www.etfdailynews.com/2023/04/09/azenta-inc-nasdaqazta-shares-sold-by-inspire-investing-llc/
Vanguard Group Inc. boosted its holdings in Azenta by 1.8% in the third quarter.